Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

HNGE vs LCAP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HNGE Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

HNGE Overall Winner 6-Pillar Tally: HNGE 6 – 0 LCAP Matrix Metrics: HNGE 8 – 2 LCAP

As of Nov 16, 2026, Hinge Health, Inc. (HNGE) is the stronger overall head-to-head candidate over Principal Capital Appreciation Select ETF (LCAP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HNGE carries a Unified Composite Score of 38.4/100 (SELL) at $121.29 (37.2x Forward P/E, 18.8% operating margin), whereas LCAP carries 53.9/100 (HOLD) at $32.67 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While LCAP currently prints a higher short-term Unified Composite Score (53.9/100 HOLD vs. HNGE 38.4/100 SELL), HNGE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (18.8% vs. N/A operating margin) and revenue trajectory (+52.4% vs. N/A YoY).
  • Technical & Structure Timing Caution: HNGE trades in a Markup technical trend (BREAKOUT options phase, RSI 61.8); meanwhile LCAP is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HNGE vs LCAP
HNGE NYSE Head-to-Head Winner
Hinge Health, Inc.
Services-Computer Processing & Data Preparation
$121.29
+5.11% 1D
Market Cap $9.4B
TTM Revenue $1.43B
Forward P/E 37.2x
Beta / 30D Vol 1.14β · 42% Vol
Unified Composite Score
38.4 / 100 SELL
Tech 10.0 Fund 32.0 Flow 57.0 Mom 31.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (11.4% over 20 days), RSI 62
RSI-14: 61.8 · SMA20: $116.14 · SMA50: $104.43
LCAP Cboe BZX
Principal Capital Appreciation Select ETF
Services-Computer Processing & Data Preparation
$32.67
-1.73% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.93β · 21% Vol
Unified Composite Score
53.9 / 100 HOLD
Tech 52.0 Fund 60.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.5%) with fading momentum, RSI 41
RSI-14: 40.6 · SMA20: $33.36 · SMA50: $33.64

6-Pillar Scorecard Institutional Category Breakdown (HNGE 6 – 0 LCAP)

Columns: Metric · HNGE · LCAP
1. Valuation Multiples HNGE
Forward P/E 37.2x N/M
Trailing P/E 31.3x N/M
PEG Ratio N/M N/M
EV / Revenue 6.4x N/M
2. Growth & Scale HNGE
Revenue Growth (YoY) +52.4% N/A
Earnings Growth (YoY) -68.4% N/A
TTM Revenue (USD) $1.43B N/A
Market Cap $9.4B N/A
3. Profitability & Quality HNGE
Gross Margin 85.8% N/A
Operating Margin 18.8% N/A
Net Profit Margin 21.0% N/A
Return on Equity (ROE) 47.6% N/A
4. Balance Sheet & Cash Flow HNGE
Cash Generation (TTM) $562M N/A
Cash Flow Margin 39.4% N/A
Net Cash / Leverage $317M Net Cash N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning HNGE
Options Structure Phase BREAKOUT UNCLASSIFIED
Current IV / %ile 61.9% (36th %ile) N/A (N/A)
Put/Call OI Skew 0.81x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Distribution
6. R&D & Supply-Chain Moat HNGE
OpEx & R&D Intensity 67.0% of Rev ($956M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Health Information Services Operator Services-Computer Processing & Data Preparation Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HNGE (8) vs LCAP (2)
Institutional Metric HNGE LCAP Criterion Row Edge
Market Capitalization
Scale
$9.4B N/A Larger Scale HNGE
Trailing P/E Ratio
Valuation
31.3x N/M Lower Multiple HNGE
Forward P/E Ratio
Valuation
37.2x N/M Lower Multiple HNGE
Revenue Growth (YoY)
Growth
+52.4% N/A Higher Growth HNGE
Operating Margin (TTM)
Profitability
18.8% N/A Higher Margin HNGE
Net Profit Margin
Profitability
21.0% N/A Higher Margin HNGE
Return on Equity (ROE)
Capital Efficiency
47.6% N/A Higher ROE HNGE
52-Week Range Position
Momentum
95% ($30–$126) 68% ($28–$35) Stronger Trend HNGE
Beta / 30D Volatility
Risk Regime
1.14β · 42% Vol 0.93β · 21% Vol Lower Realized Risk LCAP
Unified Institutional Score
Composite Signal
38.4 / 100 (SELL) 53.9 / 100 (HOLD) Higher Composite LCAP
Trailing 12M Revenue (USD)
Operating Scale
$1.43B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
85.8% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 6.4x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$562M ($317M Net Cash) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HNGE +25.78 pp
HNGE: +22.32% · LCAP: -3.46%
3M Horizon HNGE +40.91 pp
HNGE: +37.45% · LCAP: -3.46%
6M Horizon HNGE +121.49 pp
HNGE: +121.7% · LCAP: +0.21%
1Y Horizon HNGE +178.74 pp
HNGE: +190.51% · LCAP: +11.77%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HNGE vs LCAP. Trailing 12-month operating profitability (HNGE 18.8% vs LCAP N/A) and valuation multiples (HNGE 37.2x vs LCAP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

HNGE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.43B
Gross Margin85.8%
Op. Margin18.8%
ROE / Fwd P/E47.6% · 37.2x
LCAP ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HNGE BREAKOUT
93d in phase · OBV NEUTRAL
Current IV 61.9%
IV Percentile 36th %ile
Put/Call OI Skew 0.81x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact HNGE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LCAP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LCAP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HNGE Moat Profile High-Margin Pricing Power Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $9.4B market capitalization and 18.8% operating margin.
OpEx & R&D Reinvestment 67.0% of Rev ($956M)
90D Engineering Disclosures 0 Published
LCAP Moat Profile Cyclical / Execution-Driven Positioning
Services-Computer Processing & Data Preparation Operator
Competes within the Services-Computer Processing & Data Preparation value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ HNGE vs LCAP Key Questions & Quantitative Answers

As of Nov 16, 2026, Hinge Health, Inc. (HNGE) is the stronger overall head-to-head candidate over Principal Capital Appreciation Select ETF (LCAP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HNGE carries a Unified Composite Score of 38.4/100 (SELL) at $121.29 (37.2x Forward P/E, 18.8% operating margin), whereas LCAP carries 53.9/100 (HOLD) at $32.67 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While LCAP currently prints a higher short-term Unified Composite Score (53.9/100 HOLD vs. HNGE 38.4/100 SELL), HNGE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (18.8% vs. N/A operating margin) and revenue trajectory (+52.4% vs. N/A YoY). Technical & Structure Timing Caution: HNGE trades in a Markup technical trend (BREAKOUT options phase, RSI 61.8); meanwhile LCAP is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HNGE leads the Growth & Scale pillar: HNGE posts +52.4% YoY revenue growth and -68.4% YoY earnings growth on $1.43B TTM revenue (85.8% gross margin, 18.8% operating margin), compared with LCAP at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, HNGE generates $1.43B in USD-normalized revenue versus N/A for LCAP. In operating R&D and SG&A reinvestment, HNGE deploys 67.0% of Rev ($956M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LCAP.

HNGE screens cheaper on headline valuation multiples. HNGE trades at 37.2x Forward P/E, 31.3x Trailing P/E, N/M PEG, and 6.4x EV/Revenue (39.4% FCF margin), whereas LCAP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HNGE (47.6% ROE) versus LCAP (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, HNGE carries 61.9% implied volatility (36th %ile, Balanced (25th–60th %ile)), a 0.81x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (1.14β · 42% Vol realized risk). By comparison, LCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.93β · 21% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.